Eating healthy

While pharma is still treading carefully in the field of autophagy, unsure of its use in cancer, Deerfield Management Corp. L.P. has decided the time is right to invest in the emerging translational opportunities. The company has joined with University of Texas MD Anderson Cancer Center to form Vescor LLC, and plans to submit an IND within two and a half years.

Last month, the partners spun out IP from Rutgers University and the New York University Langone Medical Center to create the virtual company, which will be run out of MD Anderson’s Institute for Applied Cancer Sciences (IACS). Financial details were not disclosed...